Prostate cancer: Radiation therapy elevates risk for future cancers – Harvard Health

September 11, 2022

Prostate cancer: Radiation therapy elevates risk for future cancers
Monkeypox: What parents need to know
Have a gas stove? How to reduce pollution that may harm health
Proton-pump inhibitors: Should I still be taking this medication?
French fries versus almonds: Calorie for calorie, which comes out on top?
An action plan to fight unhealthy inflammation
How to help your child get the sleep they need
Gyn Care 101: What to know about seeing a gynecologist
How good is your cardiometabolic health — and what is that, anyway?
Poison ivy: Scratchin’ like a hound?
Men’s Health
Tightly cropped photo of a sheet of paper showing prostate cancer test results with a blood sample tube, stethoscope, and a pen all resting on top of it
A standard treatment for localized prostate cancer — meaning cancer that is confined to the prostate gland — is to kill or shrink tumors with radiation. The long-term outcomes for most men treated this way are excellent. But as with other cancer treatments, radiation involves a certain amount of risk, including the possibility that it might cause secondary cancers to form in the body later.
Secondary cancers are defined by whether they meet certain criteria:
Historical evidence shows secondary cancers occur rarely. Now, a large study of men treated with current radiation delivery methods used in the modern era updates this conclusion.
Investigators reviewed data from 143,886 men who were treated for localized prostate cancer at Veterans Affairs medical facilities between 2000 and 2015. The men ranged from 60 to 71 years in age, and came from diverse racial and ethnic backgrounds. Among them, 52,886 were treated with radiation within a year of being diagnosed. The other 91,000 men opted either for surgery over a similar time frame, or chose to have their cancers monitored and treated only when — or if — routine exams showed signs of progression.
After a median follow-up of nine years, 3% of the radiation-treated men had developed secondary cancers, compared to 2.5% of the men who chose other options. The four most common cancers — in the order of how frequently they were detected — were bladder cancer, leukemia, lymphoma, and rectal cancer. The risk of developing these secondary cancers increased steadily with time, peaking five to six years after radiation treatment was finished.
Dr. Oliver Sartor, an oncologist at Tulane University School of Medicine in New Orleans who was not involved in the study, says the potential for secondary cancers is an important issue that men should discuss with their doctors when evaluating treatment options.
Unfortunately, doctors have only limited ability to predict which radiation-treated men are at greatest risk of secondary cancers. Smoking is a major risk for bladder cancer, "so men who smoke while undergoing radiation have yet another reason to quit," Dr. Sartor says. Men with inherited risks for Lynch syndrome (a type of colorectal cancer) also face higher risks from radiation. These men have gene mutations that make it harder for their cells to repair DNA damage.
Noting that Dr. Sartor makes excellent and actionable points, Dr. Marc Garnick, the Gorman Brothers Professor of Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center, and editor of the Harvard Health Publishing Annual Report on Prostate Diseases, agrees that patients considering radiation should be informed that the treatment puts them at a small but real lifetime risk of secondary cancers, especially of the rectum and bladder, which can show up years after completing radiation therapy.
Dr. Garnick says he is reluctant to consider radiation for men with a history of inflammatory bowel diseases such as ulcerative colitis, who are also at greater risk of developing abdominal cancers. He also advises older men who were treated with radiation for prostate cancer to consult with their doctors before they stop routine colorectal screening.
Charlie Schmidt, Editor, Harvard Medical School Annual Report on Prostate Diseases
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
Post a comment: Log in and leave a comment of your own.
Men’s Health
Men’s Health
Men’s Health
Get the latest in health news delivered to your inbox!
© 2022 by The President and Fellows of Harvard College
Do not sell my personal information | Privacy Policy
Thanks for visiting. Don’t miss your FREE gift.
The Best Diets for Cognitive Fitness, is yours absolutely FREE when you sign up to receive Health Alerts from Harvard Medical School
Sign up to get tips for living a healthy lifestyle, with ways to fight inflammation and improve cognitive health, plus the latest advances in preventative medicine, diet and exercise, pain relief, blood pressure and cholesterol management, and more.
Health Alerts from Harvard Medical School
Get helpful tips and guidance for everything from fighting inflammation to finding the best diets for weight loss…from exercises to build a stronger core to advice on treating cataracts. PLUS, the latest news on medical advances and breakthroughs from Harvard Medical School experts.
BONUS! Sign up now and
get a FREE copy of the
Best Diets for Cognitive Fitness
Stay on top of latest health news from Harvard Medical School.
Plus, get a FREE copy of the Best Diets for Cognitive Fitness.


Article Tags:
Article Categories:

Leave a Reply

Your email address will not be published.

The maximum upload file size: 512 MB. You can upload: image, audio, video, document, spreadsheet, interactive, text, archive, code, other. Links to YouTube, Facebook, Twitter and other services inserted in the comment text will be automatically embedded. Drop file here